Chemical biotechnology pharmaceutical biotechnology. Web alert

A selection of World Wide Web sites relevant to papers published in this issue of Current Opinion in Biotechnology.     

Pharmaceutical biotechnology: Chemical biotechnology: Web alert

A selection of World Wide Web sites relevant to papers published in this issue of Current Opinion in Biotechnology.     

Environmental carcinogenesis and biotechnology.

Numerous environmental and host factors, some of which are known and some unknown, contribute to cancer development. While data and studies abound, our current understanding of the relation between cancer and the environment is still very limited. Understanding environmental carcinogenesis is critical to its effective management. Biotechnology has revolutionalized the study of biological and biomedical sciences. This minireview provides an overview of environmental carcinogenesis with emphasis on the contributions and prospects of biotechnology in advancing an understanding of environmental carcinogenesis for its prevention and intervention.     

On-line measurement in biotechnology: techniques.

Bioprocesses are generally ill controlled. This is due to the fact that the measurement of relevant variables is difficult. Therefore, fundamental knowledge of metabolic interrelations is, at least in vivo, limited. In this article, some of the most important measurement techniques are reviewed in order to provide an evaluation of their current state. Emphasis is given to the underlying principles and on-line capability which allow to judge their importance and potential for exploitation resulting in well (maybe entirely) controlled bioprocesses in the future.     

The management and coordination of biotechnology in the U.K. 1980-88

Government policy towards biotechnology has come a long way since the Spinks Report. Spinks advocated centralized coordination of policy, an approach deliberately rejected in 1981 by the Government in favour of continued pluralism, with each of the scientific research councils and various ministries 'doing their own thing'. This has led to considerable diversity of activity, and during these eight years more has in fact been achieved than is often recognized. But it also created an overlapping of responsibilities with concomitant friction and bad feeling that has wasted time and resources. The paper argues that some degree of friction is inevitable. By their nature new technologies cut across existing disciplines and blur institutional boundaries. The traditional approach has been to muddle through, allowing new institutions to emerge and adapting the old as seems appropriate. Lack of resources, however, argues against too brash a competitive approach. The paper suggests that strategic or precompetitive research should be seen as a complement to, rather than competitive with basic research, and cautions against too radical a restructuring of institutions at the present time.     

Pharmaceutical biotechnology, Chemical biotechnology: Web alert

A selection of World Wide Web sites relevant to papers published in this issue of Current Opinion in Biotechnology.